Author

Eric Zillich

Heidelberg UniversityPrimary ORCID profile (0000-0001-7457-374X · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Eric ZillichiD2 papers · Heidelberg University

Biology Disciplines

Click to filter author papers

Genomics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Lea Zillich· 2 shared Stephanie H. WittiD· 2 shared Ammar JabaliiD· 1 shared André Tadić· 1 shared Andrea Carlo RossettiiD· 1 shared Andreas HentscheliD· 1 shared Andreas RoosiD· 1 shared Annasara Artioli· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Lea Zillich

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dynamic Epigenetic Changes During Antidepressant Pharmacotherapy in Major Depressive Disorder

Svenja Müller, Josef Frank, Eric Zillich, Fabian Streit, Valentin Nicolai Koch, Miriam A. Schiele, Katharina Domschke, André Tadić, David P. Herzog, Stefanie Wagner, Marianne B. Mueller, Giulia Treccani, Nils C. Gassen, Marcella Rietschel, Stephanie H. Witt, , Lea Zillich

This study identifies DNA methylation changes over time during antidepressant treatment in MDD, linking them to neuroplasticity and inflammation, and shows differences between responders and non-responders.

bioRxiv · Nov 20, 2025 · PreprintGenomics

Capturing the biology of disease severity in an organoid model of LIS1-lissencephaly

Lea Zillich, Matteo Gasparotto, Andrea Carlo Rossetti, Olivia Fechtner, Camille Maillard, Anne Hoffrichter, Eric Zillich, Ammar Jabali, Fabio Marsoner, Annasara Artioli, Ruven Wilkens, Christina B. Schroeter, Andreas Hentschel, Stephanie H. Witt, Nico Melzer, , Julia Ladewig

This study uses LIS1-lissencephaly patient organoids to identify severity-dependent phenotypes and molecular mechanisms, and demonstrates that mTOR inhibitors can rescue disease-related changes.

bioRxiv · Dec 19, 2022 · PreprintNeuroscience